VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
46,870MODERNA
532GLAXOSMITHKLINE BIOLOGICALS
353PFIZER\BIONTECH
231MERCK & CO. INC.
221UNKNOWN MANUFACTURER
62SEQIRUS, INC.
25DYNAVAX TECHNOLOGIES CORPORATION
13EMERGENT BIOSOLUTIONS
12SANOFI PASTEUR
9NOVARTIS VACCINES AND DIAGNOSTICS
5PFIZER\WYETH
5PAXVAX
2TEVA PHARMACEUTICALS
2PROTEIN SCIENCES CORPORATION
1BERNA BIOTECH, LTD.
1INTERCELL AG
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL1,906
1,575
289
IMM209286
252
236
229
s029456178
171
UT7065MA166
155
149
145
S034636133
107
U62828AA103
100
98
P10025327596
U6737AA85
UJ446AA79
78
78
59
57
4BH3254
4F47253
52
27656352
50
PP9L548
49TM346
42
40
38
MENVEO38
4F47237
R1B252M36
34
C5763AA30
93362229
25
300057A24
UNK24
22
CW311621
18
17
15
UH894AB15
3Y7NL12
R1B743M12
EJ168611
el128410
10
10
10
9
ARBA141A9
UNK9
8
UNK8
8
1F4EB8
Unknown7
7
No batch number6
5
5
UJ090AA5
5
5
4
4
4
UNK4
JEV18K95E4
UNK3
A115A3
Z127A3
3
3333324181073
2
2
2
TAR352
1
1
1
1
1
A739081
1
1
1
1
1
037K20A68,542
EL128447,700
133

Incidents per State

State Total
15,185
CA14,096
NY7,507
TX7,196
FL6,939
IN5,527
PA4,560
IL4,179
OH4,054
AZ3,856
MI3,771
NJ3,411
MA3,278
VA3,208
NC3,114
WA3,034
GA2,864
MD2,652
MN2,534
CO2,532
WI2,457
MO2,029
OR1,943
TN1,715
CT1,693
KY1,603
OK1,226
AL1,201
KS1,162
IA1,157
SC1,106
NM1,065
UT973
AR951
LA945
NE829
NV797
ME795
MT789
NH756
ID674
AK661
WV661
PR650
MS585
HI536
RI510
VT441
SD361
ND356
DE350
DC239
WY209
GU32
AS16
VI13
MP9
MH3
FM2
QM1
XB1

ID: 0920972
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/05/2021
Hospital:

Lab Data: Test Name: COVID-19 rapid test; Test Result: Positive

Allergies:

Symptoms: positive COVID-19 rapid test with symptoms; positive COVID-19 rapid test with symptoms; headache; nasal congestion; This is a spontaneous report from a contactable physician. A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, on an unspecified date at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced positive COVID-19 rapid test with symptoms, headache and nasal congestion on an unspecified date. The patient developed headache and nasal congestion by the third day after the vaccination. The patient underwent lab tests and procedures which included COVID-19 rapid test: positive on an unspecified date. The clinical outcome of positive COVID-19 rapid test with symptoms, headache and nasal congestion was unknown. The batch/lot number for the vaccine, BNT162B2, was not provided and has been requested during follow up.; Sender's Comments: The reported positive COVID-19 rapid test with symptoms after COVID-19 immunization is considered ineffective of BNT162B2, and the Company cannot completely exclude the possible causality between the reported event and BNT162B2 administration.

Other Meds:

Current Illness:

ID: 0920973
Sex: F
Age:
State: PA

Vax Date: 12/21/2020
Onset Date: 12/25/2020
Rec V Date: 01/05/2021
Hospital:

Lab Data: Test Date: 20201225; Test Name: Covid; Result Unstructured Data: Test Result:Positive

Allergies:

Symptoms: positive COVID-19 test with symptoms; positive COVID-19 test with symptoms; This is a spontaneous report from a contactable nurse (patient). A 37-year-old female patient received their first dose of BNT162B2 (lot number: EL0140; expiry date unknown), intramuscular on 21Dec2020 at single dose for COVID-19 immunization. Medical history included congestion and dry cough (before vaccination), and not tasting anything from an unknown date. Concomitant medication included vitamins. The patient reported that they just have the concern about the vaccination last Monday that was 21Dec2020, on 25Dec2020, Christmas day they were diagnosed with Covid. They were thinking because the day before their vaccination they already had like some kind of congestion and also some kind of dry cough but they didn't really think that it was Covid but they were still able to get the vaccination on Monday. When they started to feel like they were not tasting anything, that's when they decided to get tested and it turns out to be positive. They were confirmed positive on the 25th but in their mind they were probably having Covid since the day before they got they vaccination. So their worry is, is there any effect where they got the vaccine where they already have the Covid in their body. So that is really their worry right now. The patient underwent lab tests and procedures which included SARS-CoV-2 test: positive on 25Dec2020. The outcome of the events was unknown.; Sender's Comments: The association between the event drug ineffective (COVID-19) with BNT162b2 can not be completely excluded.

Other Meds:

Current Illness:

ID: 0920974
Sex: F
Age:
State:

Vax Date: 12/18/2020
Onset Date: 12/22/2020
Rec V Date: 01/05/2021
Hospital:

Lab Data:

Allergies:

Symptoms: developed rashes on the chest area, not spreading; This is a spontaneous report from a contactable nurse (patient). A 43-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number EK5730), via an unspecified route of administration into the left deltoid on 18Dec2020 as the first single dose for covid-19 immunization. Medical history was reported as none. Concomitant medication included rosuvastatin calcium (CRESTOR). The patient developed rashes on the chest area, not spreading on 22Dec2020. The event as reported between not serious and medically significant by the reporter. Details were as follows: and patient was a nurse that had her vaccine through her workplace on 18Dec2020, so she was 10 days out, and noticed a rash on her chest on day 4, which was still present. It did not seem to be spreading, and she could not think of any reason for the reaction. She was scheduled to receive the second dose in three weeks. The outcome of developed rashes on the chest area, not spreading was not recovered. The relatedness of the event to the suspect drug was reported as unknown from the reporter.; Sender's Comments: Based on the information currently provided, the vaccination with BNT162B2 might play a contributory role in triggering the onset of rash. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Other Meds: CRESTOR

Current Illness:

ID: 0920975
Sex: F
Age:
State: OK

Vax Date: 12/18/2020
Onset Date: 12/01/2020
Rec V Date: 01/05/2021
Hospital:

Lab Data: Test Date: 202012; Test Name: eye examination; Result Unstructured Data: Test Result:little spots on the inside of her eyelids

Allergies:

Symptoms: blurred vision; little spots on the inside of her eyelids; This is a spontaneous report from a contactable nurse (patient). A 53-year-old female patient received first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot number and expiry date were unknown), via an unspecified route of administration on 18Dec2020 at a single dose for COVID-19 immunization. Medical history included eyeglasses wearer (reported as with her glasses). The patient's concomitant medications were not reported. The patient is experiencing symptoms from the COVID-19 vaccine received on 18Dec2020. She began to have blurred vision that night, and it worsened over the following weekend. She saw the eye doctor on 22Dec2020, and they stated her vision had changed even with her glasses. Now she has little spots on the inside of her eyelids that were also noticed on the eye examination in Dec2020. She has already reported these symptoms to the V-safe program. She mentioned that she is not the only nurse in the workplace that has experienced blurry vision. She asked if she should receive the second dose on 08Jan2021. It was still blurry, but it was better than it was a week ago. It still affected her reading and seeing at a distance. It scared her to get the second one because she doesn't want to go blind. She went to the eye doctor for visit on Tuesday. The outcome of the event blurred vision was recovering, while for the other event was unknown. The reporter considered blurred vision as serious due to being medically significant. Information about lot/batch number has been requested.; Sender's Comments: There is not a reasonable possibility that the reported event vision blurred and eyelid disorder related to the suspect product event most likely due to patient underlying contributory factors

Other Meds:

Current Illness:

ID: 0920976
Sex: U
Age:
State: AL

Vax Date:
Onset Date:
Rec V Date: 01/05/2021
Hospital:

Lab Data: Test Name: COVID-19 test; Test Result: Positive

Allergies:

Symptoms: positive COVID-19 test; positive COVID-19 test; This is a spontaneous report from a contactable pharmacist. A patient of unspecified age and gender received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, on an unspecified date at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced positive COVID-19 test on an unspecified date. The patient underwent lab tests and procedures which included COVID-19 test: positive on an unspecified date. The clinical outcome of positive COVID-19 test was unknown. The batch/lot number for the vaccine, BNT162B2, was not provided and has been requested during follow up.; Sender's Comments: The reported positive COVID-19 test after COVID-19 immunization is considered ineffective of BNT162B2, and the Company cannot completely exclude the possible causality between the reported event and BNT162B2 administration.

Other Meds:

Current Illness:

ID: 0920977
Sex: M
Age:
State: IN

Vax Date: 12/18/2020
Onset Date: 12/26/2020
Rec V Date: 01/05/2021
Hospital:

Lab Data:

Allergies:

Symptoms: body aches; headache; congestion; This is a spontaneous report from a contactable physician (patient). A 32-years-old male patient received his first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 18Dec2020 at a single dose for Covid-19 immunization. The patient medical history was not reported. The patient's concomitant medications were not reported. The doctor (HCP) received his 1st vaccination on 18Dec2020. He started having symptoms on 26Dec2020. These symptoms are "body aches, headache and congestion." Outcome of the events was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0920978
Sex: F
Age:
State: GA

Vax Date: 12/22/2020
Onset Date: 12/23/2020
Rec V Date: 01/05/2021
Hospital:

Lab Data: Test Name: fever; Result Unstructured Data: Test Result:fever

Allergies:

Symptoms: very sick; chills; fever; diarrhea; vomiting; This is a spontaneous report from a contactable other hcp. A 41-year-old female patient received bnt162b2 (lot number: EH9899), intramuscularly at arm left, first dose on 22Dec2020, at single dose, for COVID-19 immunization. The patient medical history and concomitant medications were not reported. It was reported that the patient got the vaccination yesterday (22Dec2020) and she has been very sick, chills, fever, diarrhea and vomiting. Didn't come to work today and she claims is getting worse. The event was unwitnessed by staff and the reported by client employer. Age at vaccination is 41 years old. Adverse event started on 23Dec2020. The event was reported as non-serious. The outcome of the events was unknown.

Other Meds:

Current Illness:

ID: 0920979
Sex: F
Age:
State:

Vax Date: 12/16/2020
Onset Date: 12/01/2020
Rec V Date: 01/05/2021
Hospital:

Lab Data: Test Date: 202012; Test Name: COVID-19; Result Unstructured Data: Test Result:positive

Allergies:

Symptoms: having symptoms/She tested positive to COVID-19; having symptoms/She tested positive to COVID-19; This is a spontaneous report from a contactable nurse (patient). A 30-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 16Dec2020 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient started having symptoms on Thursday. On Friday, her supervisor had her get tested for COVID. She tested positive to COVID-19 in Dec2020. Outcome of the events was unknown. The patient wanted to know if she is symptom free, should/can she still get the 2nd dose as planned. Information on the lot/batch number has been requested.; Sender's Comments: Based on the information available, a possible contributory role of the suspect products cannot be excluded for the reported event of positive for corona virus infection for the lack of efficacy of the vaccine. However, based on the mechanism of action of the vaccine, it is unlikely the patient would have fully developed immunity for the vaccine to be effective, due to the single dose and short duration

Other Meds:

Current Illness:

ID: 0920980
Sex: F
Age:
State: NJ

Vax Date: 12/24/2020
Onset Date: 12/25/2020
Rec V Date: 01/05/2021
Hospital:

Lab Data:

Allergies:

Symptoms: single hive on abdomen (itchy)/full body hives and itching; single hive on abdomen (itchy)/full body hives and itching; This is a spontaneous report from a contactable Physician. A 36-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number EL0140, expiry date unknown) intramuscular at left arm on 24Dec2020 at single dose for Covid-19 immunization in a hospital facility. Medical history included Anxiety, Hypertension, and GERD (gastrooesophageal reflux disease). The patient was not diagnosed with Covid-19 prior to vaccination. Concomitant medications included diphtheria vaccine toxoid, pertussis vaccine acellular, tetanus vaccine toxoid (TDAP) on 08Dec2020 for immunization; bupropion hydrochloride (WELLBUTRIN), amlodipine, omeprazole; from unspecified date for unspecified indication. On 25Dec2020, the patient developed a single hive on abdomen (itchy), and on 26Dec2020 the patient developed full body hives and itching but spared the face and mucosal surfaces. The patient has no swelling, no respiratory symptoms. The patient has not been tested for Covid-19 since the vaccination. The patient received treatment of antihistamines (steroids if no improvement) on unspecified date. The hives responded to antihistamines temporarily. The outcome of the event single hive on abdomen (itchy)/full body hives and itching was not recovered. The reporter considered the events non-serious; did not results in death, was not life threatening, did not caused/prolonged hospitalization, was not disabling/incapacitating, not a congenital anomaly/birth defect.; Sender's Comments: Based on the information available, a possible contributory role of the suspect products cannot be excluded for the reported event hives and itching due to temporal association.

Other Meds: WELLBUTRIN; ;

Current Illness:

ID: 0920981
Sex: F
Age:
State: AR

Vax Date:
Onset Date:
Rec V Date: 01/05/2021
Hospital:

Lab Data: Test Name: Covid test; Test Result: Positive

Allergies:

Symptoms: ended up testing positive for COVID virus after receiving the first dose of Pfizer-BioNTech COVID-19 Vaccine/ She had symptoms; ended up testing positive for COVID virus after receiving the first dose of Pfizer-BioNTech COVID-19 Vaccine/ She had symptoms; This is a spontaneous report from a contactable nurse. This nurse reported similar events for two patients. This is 1st of two reports. A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EH9899; expiry date unknown), via an unspecified route of administration, on an unspecified date, at 0.3 mL, single for COVID-19 vaccination. The patient's medical history and concomitant medications were not reported. The nurse reported on an unspecified date that the patient tested positive after the first dose. The reporter works in employee health at their hospital. The employee ended up testing positive for COVID virus after receiving the first dose of Pfizer-BioNTech COVID-19 Vaccine. She had symptoms the first 2-3 days after getting the vaccine and assumed it was a normal immune response, but after that she continued to have the symptoms. They went to see the provider and tested positive for COVID virus. They were asking how to handle their second doses. Outcome of the events was unknown.; Sender's Comments: Based on the information available, a possible contributory role of the suspect products cannot be excluded for the reported event of corona virus infection for the lack of efficacy of the vaccine. However, based on the mechanism of action of the vaccine, it is unlikely the patient would have fully developed immunity for the vaccine to be effective, due to the short duration of less than 5 days since the vaccine first dose is given.,Linked Report(s) : US-PFIZER INC-2020516628 same reporter, same drug, same event, different patient.

Other Meds:

Current Illness:

ID: 0920982
Sex: F
Age:
State: TX

Vax Date: 12/18/2020
Onset Date: 12/18/2020
Rec V Date: 01/05/2021
Hospital:

Lab Data:

Allergies:

Symptoms: nausea/waves of nausea; lower abdominal pain; headache; This is a spontaneous report from a contactable consumer (patient). A 60-year-old female patient received bnt162b2 (BNT162B2; reported as COVID19 Vaccine; lot number: EJ1685; expiration date: Mar2021), via an unspecified route of administration right arm on 18Dec2020 15:00 at single dose for Covid-19 vaccination. Medical history included IBS (irritable bowel syndrome), hysterectomy at age 42 and she doesn't have periods (amenorrhea). The patient family medical history included her family are all dead and has been for a long time. The patient's concomitant medications were not reported. It was reported that vaccinations within 4 weeks included shingles vaccination 5 weeks before covid-19 vaccine wherein the patient first singles shot was fine. Her second shingles shot made her sick, body aches, and fever for about 24 hours. She received it from a pharmacy inside a store. The reporter mentioned that she took her first covid vaccine shot and was able to experience nausea, headache lower abdominal pain. She inquired if there was information on until when she will be experiencing this or how long the symptoms will last. She mentioned that she had headaches and waves of nausea, and before nausea, she had lower abdominal pain. She doesn't know if abdominal pain was coincidental. She had a hysterectomy, so she doesn't have periods. She lives with IBS, but this abdominal pain was different. Immediately after COVID-19 Vaccine within about 20 minutes after injection (18Dec2020 15:20), she had headaches and she still has been having headaches. She had strange lower abdominal pain that lasted a minute and a half then shortly after that started having waves of nausea. She added that the waves of nausea began 24 hours after the COVID-19 Vaccine (19Dec2020 15:00). The outcome of the event headache was not recovered, as for nausea was unknown while the outcome of the other event was recovered on Dec2020.

Other Meds:

Current Illness:

ID: 0920983
Sex: F
Age:
State: AK

Vax Date: 12/22/2020
Onset Date: 12/23/2020
Rec V Date: 01/05/2021
Hospital:

Lab Data: Test Name: Nasal Swab; Result Unstructured Data: Test Result:Negative

Allergies:

Symptoms: Sore left arm 2-3 days after vaccinated; This is a spontaneous report from a contactable consumer. A 56-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), Lot: EK5730, via an unspecified route of administration, in the left arm, from 22Dec2020 09:15 at a single dose for COVID-19 immunization. Medical history included allergies to penicillin, gluten, chicken eggs (whites & yolks) and cow's milk. Patient was not pregnant. The patient's concomitant medications were not reported. on 23Dec2020 09:00, after being vaccinated, the patient experienced sore left arm for 2-3 days. The patient underwent lab tests and procedure on unspecified date which included Nasal Swab test/COVID test, yielding negative result. The outcome of event was recovered on Dec2020. Follow-up attempts are completed. Information on the batch/lot number has been obtained.

Other Meds:

Current Illness:

ID: 0920984
Sex: F
Age:
State: NV

Vax Date: 12/23/2020
Onset Date: 12/24/2020
Rec V Date: 01/05/2021
Hospital:

Lab Data:

Allergies:

Symptoms: lost sense of smell; cold like symptoms; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 23Dec2020 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced cold like symptoms on 24Dec2020. Then on the 26th (26Dec2020), patient lost sense of smell. Outcome of events was unknown. Follow-up attempts are completed. The following information on the batch number has been requested.

Other Meds:

Current Illness:

ID: 0920985
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/05/2021
Hospital:

Lab Data: Test Name: COVID-19; Test Result: Positive

Allergies:

Symptoms: a patient received Pfizer COVID-19 vaccine, couple of days later the patient tested positive for COVID-19; a patient received Pfizer COVID-19 vaccine, couple of days later the patient tested positive for COVID-19; This is a spontaneous report from a contactable pharmacist. A patient of unspecified age and gender received the first dose of BNT162B2 (Pfizer-Biontech Covid-19 Vaccine) via an unspecified route of administration on an unspecified date at a single dose as Pfizer COVID-19 vaccine. Medical history and concomitant medications were not reported. It was reported that on an unspecified date, a patient received Pfizer COVID-19 vaccine, couple of days later the patient tested positive for COVID-19, patient subsequently received monoclonal antibody treatment: a combination of Casirivimab and Imdevimab. It was inquired if the patient could receive the second dose of COVID-19 vaccine. The outcome of the events was unknown. Information about Lot/batch number has been requested.; Sender's Comments: Based on available information, a possible contributory role of BNT162B2 vaccine cannot be excluded for the reported events of LOE and COVID 19. There is very limited information provided in this report. This case will be reassessed upon receipt of follow-up information. Based on the information provided in the case, this individual report would not seem to modify the risk-benefit profile of the subject product.

Other Meds:

Current Illness:

ID: 0920986
Sex: U
Age:
State:

Vax Date: 12/23/2020
Onset Date: 12/24/2020
Rec V Date: 01/05/2021
Hospital:

Lab Data: Test Date: 20201225; Test Name: get tested; Test Result: Positive

Allergies:

Symptoms: I took the vaccine and two days after I tested positive/had lost my sense of smell and taste; I took the vaccine and two days after I tested positive/had lost my sense of smell and taste; Lost my sense of smell and taste; Lost my sense of smell and taste; This is a spontaneous report from a non-contactable consumer (patient). A patient of unspecified age and gender received BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; lot/batch number and expiry date were unknown), via an unspecified route of administration on 23Dec2020 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The consumer stated that he/she just got the vaccine on Wednesday (23Dec2020), and he/she started experiencing some symptoms on 24Dec2020 where he/she had lost his/her sense of smell and taste. On 25Dec2020, he/she went 'health' to get tested, and he/she tested positive. The consumer is asking whether this has been reported that one of the side effects of getting the vaccine. The consumer said he/she hasn't read anything about loss of taste and smell after taking the vaccine. He/she was wondering if this has been reported or this is one of those small side effects that the vaccine has. The consumer further stated that he/she took the vaccine and two days after, he/she tested positive. Now, his/her whole family is also positive but only his/herself had the vaccine, because he/she is the only one that works in healthcare (further clarification was unknown, hence reporter was captured as consumer). The outcome of the events was unknown. No follow-up attempts are possible; Information about lot/batch number could not be obtained. No further information is expected.; Sender's Comments: The association between the event lack of effect (COVID19, lost of taste and smell) with BNT162b2 can not completely excluded.

Other Meds:

Current Illness:

ID: 0920987
Sex: U
Age:
State: AR

Vax Date:
Onset Date:
Rec V Date: 01/05/2021
Hospital:

Lab Data: Test Name: COVID virus; Test Result: Positive

Allergies:

Symptoms: ended up testing positive for COVID virus after receiving the first dose of Pfizer-BioNTech COVID-19 Vaccine/had symptoms; ended up testing positive for COVID virus after receiving the first dose of Pfizer-BioNTech COVID-19 Vaccine/had symptoms; This is a spontaneous report from a contactable nurse. This nurse reported similar events for two patients. This is the 2nd of two reports. A patient of an unspecified age and gender received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, strength: 0.3 mL, lot number: EH9899; expiry date was unknown), via an unspecified route of administration on an unspecified date at 0.3 mL, single for COVID-19 vaccination. The patient's medical history and concomitant medications were not reported. The patient ended up testing positive for COVID virus after receiving the first dose of Pfizer-BioNTech COVID-19 Vaccine. The patient had symptoms the first 2-3 days after getting the vaccine and assumed it was a normal immune response, but after that the patient continued to have the symptoms. The patient went to see the provider and tested positive for COVID virus. The patient was asking how to handle his/her second dose. The outcome of the event was unknown.; Sender's Comments: Based on the information currently provided, the company considers that a causal relationship between the COVID-19 and vaccination with BNT162B2 cannot be excluded.,Linked Report(s) : US-PFIZER INC-2020516297 same reporter, same event, different patient.

Other Meds:

Current Illness:

ID: 0920988
Sex: F
Age:
State: CA

Vax Date: 12/23/2020
Onset Date: 12/24/2020
Rec V Date: 01/05/2021
Hospital:

Lab Data:

Allergies:

Symptoms: stiffness; Spreading from my shoulder up my neck to the base of my skull/worsening pain; Limited ROM; Horrific pain upon turning my neck towards the left; Woke up the following morning with a kink in my left neck; This is a spontaneous report from a contactable nurse, the patient. A 44-year-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ECT1685), via an unspecified route of administration in the left arm on 23Dec2020 at 13:15 (at the age of 44-years-old) as a single dose for COVID-19 immunization. Medical history included anxiety, depression, hypothyroidism, lumbar fusion, and penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included sertraline hydrochloride (ZOLOFT), colecalciferol (VIT D3), and alprazolam (XANAX). The patient did not receive any other vaccines within four weeks prior to the vaccination. On 24Dec2020 at 09:00, the patient woke up the following morning with a kink in her left neck, which was similar to sleeping awkwardly. She applied some heat and took some ibuprofen (ADVIL). It persisted on 25Dec2020 and she did the same treatment. On 26Dec2020, the pain was exponentially worse and spreading from her shoulder up her neck to the base of her skull. She had limited range of motion. She had horrific pain upon turning her neck towards the left. She went to the emergency room on 27Dec2020 and 28Dec2020 due to the worsening pain, stiffness, and loss of function. The patient was treated with ibuprofen and unspecified muscle relaxers. The patient had not been tested for COVID-19 post vaccination. The clinical outcomes of the kink in her neck, neck pain, limited range of motion, worsening pain, and stiffness, were not recovered. The events were all reported as non-serious.

Other Meds: ZOLOFT; VIT D3; XANAX

Current Illness:

ID: 0920989
Sex: F
Age:
State: CA

Vax Date: 12/18/2020
Onset Date: 12/27/2020
Rec V Date: 01/05/2021
Hospital:

Lab Data: Test Date: 20201227; Test Name: Covid test; Result Unstructured Data: Test Result:positive; Comments: She had a positive Covid test result yesterday

Allergies:

Symptoms: tested positive after receiving Covid-19 vaccine; tested positive after receiving Covid-19 vaccine; This is a spontaneous report from a contactable nurse. A 38-years-old female patient started received her first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date not reported), via an unspecified route of administration on 18Dec2020 at a single dose for prevention of Covid 19. The patient medical history and concomitant medications were not reported. The nurse reported that a staff member received the first dose of Covid-19 vaccine on 18Dec2020. Approximately 9 days later, on 27Dec2020, the patient developed/experienced tested positive after receiving Covid-19 vaccine. The seriousness criteria for this event was none. The nurse asked if the patient will be able to receive the second dose and what is the advice for the patient. The outcome of the event was unknown. The reporter considered the relationship of the event to treatment with BNT162B2 as not applicable. Information about lot/batch number was requested.; Sender's Comments: Based on the information available, a possible contributory role of the suspect BNT162B2 cannot be excluded for the reported event tested positive Covid-19 based on the known safety profile. However the short duration of 9 days since the vaccine first dose is given it is unlikely patient would have fully developed immunity.

Other Meds:

Current Illness:

ID: 0920990
Sex: F
Age:
State: OK

Vax Date: 12/22/2020
Onset Date: 12/22/2020
Rec V Date: 01/05/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Flush; Itching; felt like she was going to wet herself; This is a spontaneous report from a contactable consumer. A 58-year-old female patient received the bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot Number: EK5730 and Expiration Date: unknown), intramuscularly in the upper left arm on 22Dec2020 at 08:48 at 58-years-old at a single dose for COVID-19 immunization; which was received at a hospital. The patient stated the hospital had a line for employees to drive up and receive the vaccine, she was in her car when the vaccine was administered. Medical history included ongoing allergy to sulfates from an unknown date (diagnosed at least 20 years ago). The patient had an allergy to sulfates. The patient had a bad reaction to sulfamethoxazole and trimethoprim (BACTRIM) many years ago. The patient did not have the Lot and NDC numbers, or expiration date to provide. The patient stated the reaction was so bad she had to receive multiple injections because her throat was closing off and she had big hives. This occurred years ago. There were no concomitant medications. The patient previously took sulfamethoxazole and trimethoprim (BACTRIM) and experienced bad reaction, throat was closing off and big hives from an unknown date to an unknown date. On 22Dec2020, the patient experienced: flush, itching, and felt like she was going to wet herself; all assessed as non-serious. The patient called about the COVID-19 vaccine. The patient was wondering if there was any sulfa in the vaccine. The patient had the vaccine on 22Dec2020, and she was fine for the first hour and then she became flush and started itching an hour later. The patient stated " you know when you get a CT scan and the contrast makes you feel warm down there", states she got that same feeling where she felt flush and where she was warm down there and she felt like she was going to wet herself. The patient stated, "the bladder feeling came on so harsh and fast." The patient took diphenhydramine hydrochloride (BENADRYL) for two days and she felt better. The patient later clarified that she recovered completely as of 25Dec2020. Therapeutic measures were taken as a result of flush and itching. The clinical outcome of the events, flush and itching, was recovered on 22Dec2020. The clinical outcome of the event, felt like she was going to wet herself, was unknown. There was no history of previous immunization with the Pfizer vaccine considered as a suspect. There were no additional vaccines administered on the same date of the Pfizer suspect. The events did not require a visit to an emergency room or physician office. The patient did not receive any prior vaccinations within 4 weeks of the suspect vaccine. There were no adverse events (AEs) following prior vaccinations. There were no relevant tests performed.

Other Meds:

Current Illness: Allergy to chemicals (diagnosed at least 20 years ago)

ID: 0920991
Sex: F
Age: 51
State: NY

Vax Date: 12/24/2020
Onset Date: 12/25/2020
Rec V Date: 01/05/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Patient had GI distress (N/V/diarrhea) on 12/25

Other Meds:

Current Illness:

ID: 0920992
Sex: F
Age:
State: CA

Vax Date: 12/28/2020
Onset Date: 12/28/2020
Rec V Date: 01/05/2021
Hospital:

Lab Data: Test Date: 20201228; Test Name: heart rate; Result Unstructured Data: Test Result:rapid

Allergies:

Symptoms: lightheaded; chills; tingling/buzzing/numbness/swelling in face and lips; tingling/buzzing/numbness/swelling in face and lips; tingling/buzzing/numbness/swelling in face and lips; tingling/buzzing/numbness/swelling in face and lips; swelling in face; swelling in face and lips; rapid heart rate; flushed neck, upper chest, and face-a red rash here; This is a spontaneous report from a contactable consumer (patient). This 51-year-old female patient received the 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration at left arm on 28Dec2020 03:30 PM at single dose (lot number: EH9899) for COVID-19 immunization. Medical history included asthma and known allergies to medications, food, or other products. Concomitant medications include Estradiol received in two weeks. No other vaccine in four weeks. The patient was not pregnant. The patient experienced lightheaded; chills; tingling/buzzing/numbness/swelling in face and lips; rapid heart rate; flushed neck, upper chest, and face-a red rash here that resembled sunburn, but was not painful; on 28Dec2020 04:00 PM. The patient took antihistamine (Claritin) and rest as treatment. All events were reported as non-serious. The patient had no Covid prior vaccination, no Covid tested post vaccination. Outcome of all events was recovering.

Other Meds:

Current Illness:

ID: 0920993
Sex: F
Age:
State: VA

Vax Date: 12/17/2020
Onset Date: 12/25/2020
Rec V Date: 01/05/2021
Hospital:

Lab Data: Test Date: 20201227; Test Name: Covid test (Nasal Swab); Test Result: Positive ; Comments: tested positive for the virus yesterday

Allergies:

Symptoms: had loss of sense of smell and tested positive for the virus; had loss of sense of smell and tested positive for the virus; This is a spontaneous report from a contactable healthcare professional (patient). A 42-years-old female patient received her first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date not reported), intramuscular on 17Dec2020 at a single dose on the left arm, for Covid-19 immunization. The patient has no medical history and no concomitant medications (no other vaccines in four weeks and no other medications in two weeks prior to vaccination). The patient has no known allergies to medications, food, or other products. The patient had loss of sense of smell, no other symptoms on 25Dec2020 and tested positive for the virus yesterday, on 27Dec2020. The patient has no Covid-19 prior to vaccination. The patient underwent Covid test (Nasal Swab) and result was positive on 27Dec2020. The patient did not receive any treatment for the event. Outcome of the event was unknown. The events were assessed as non-serious by the reporter. No follow-up attempts are possible, information about lot/batch number cannot be obtained.; Sender's Comments: A possible contributory role of BNT162B2 vaccine cannot be excluded for event based on available information.

Other Meds:

Current Illness:

ID: 0920994
Sex: F
Age: 55
State: AL

Vax Date: 01/04/2021
Onset Date: 01/04/2021
Rec V Date: 01/05/2021
Hospital:

Lab Data: NONE REPORTED

Allergies: PENICILLIN-AUGMENTIN (ANAPHYLAXIS/HOSPITALIZED)

Symptoms: PATIENT VACCINATED AROUND 9AM. SHE REPORTS SHE FELT WARM/FLUSHING, FAINT AND STOMACH SPASMS WITHIN ABOUT 4-5 MINS. SHE FELT BETTER AND GOT UP TO WALK ABOUT 30 MINS LATER. SYMPTOMS WORSENED AFTER WALKING ~9:45AM: FAINT AGAIN, SEVERE RETCHING, BP196/140 TO 199/164, TROUBLE SWALLOWING, SOB, WHEEZING. AT 9:58AM, EPI PEN 0.3MG ADMINISTERED AND EMS ACTIVATED. SYMPTOMS REPORTED IMPROVED FOLLOWING EPI. EMS ARRIVED 10:05AM. PATIENT REPORTED RECEIVING 2 BAGS OF PEPCID, STEROIDS, AND ZOFRAN AT HOSPITAL. WAS RELEASED BETWEEN 11:30AM-12PM ON 1/4/21, BP 140/90 AND ACUTE SYMPTOMS RESOLVED. FOLLOW UP WITH PATIENT 1/5/21: NO PRIOR HX OF HTN, BP 120/60, NO SOB/ BREATHING DIFFICULTY. C/O SEVERE HEADACHE, LOW TEMP, FATIGUE, MUSCLE ACHES, SORE THROAT.

Other Meds: EFFEXOR 75MG QD, LIPITOR 80MG QD, FENOFIBRATE 150MG QD, ASA 81MG QD, QUERCETIN 1200MG QD, ZINC 50MG QD, VIT C 1000MG QD,

Current Illness:

ID: 0920995
Sex: F
Age:
State: MO

Vax Date: 12/21/2020
Onset Date: 12/21/2020
Rec V Date: 01/05/2021
Hospital:

Lab Data: Test Date: 20201221; Test Name: Body temperature; Result Unstructured Data: Test Result:99.6

Allergies:

Symptoms: Fever (99.6); Arm soreness; Headache; Fatigue; This is a spontaneous report from a contactable physician (patient). A 28-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number: EH9899), intramuscularly in the left arm, on 21Dec2020 at 07:15 (at the age of 28-years-old) at a single dose for COVID-19 immunization. Medical history included migraines and allergies to mango. The patient was not pregnant at the time of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications, taken within two weeks of vaccination, included magnesium (MANUFACTURER UNKNOWN) taken as supplement. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient experienced fever (99.6), arm soreness, headache, and fatigue on 21Dec2020 at 20:00. The events were reported as non-serious. The patient underwent lab tests and procedures, which included body temperature: 99.6 on 21Dec2020. No therapeutic measures were taken as a result of the events. The clinical outcome of fever (99.6), arm soreness, headache, and fatigue was recovered in Dec2020. It was also reported that since the vaccination, the patient had not been tested for COVID-19.

Other Meds:

Current Illness:

ID: 0920996
Sex: F
Age:
State: HI

Vax Date: 12/17/2020
Onset Date: 12/21/2020
Rec V Date: 01/05/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Droopy left cheek.; This is a spontaneous report from a contactable nurse. A 52-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number: EJ1685), intramuscularly in the left arm, on 17Dec2020 at 14:30 (at the age of 52-years-old) at a single dose for COVID-19 immunization. The patient had no medical history or concomitant medications. The patient had no other medications within two weeks of vaccination. The patient was not pregnant at the time of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously took sulfamethoxazole, trimethoprim (SEPTRA) and experienced allergy. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient experienced droopy left cheek on 21Dec2020. No therapeutic measures were taken as a result of the event. The clinical outcome of droopy left cheek was recovered in Dec2020. It was also reported that since the vaccination, the patient had not been tested for COVID-19.; Sender's Comments: A possible causal association between administration of BNT162B2 and the onset of droopy left cheek might not be excluded considering the plausible temporal relationship. The patient had previous allergy reaction to antibiotic (sulfamethoxazole, trimethoprim) use. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Other Meds:

Current Illness:

ID: 0920997
Sex: F
Age: 51
State: NM

Vax Date: 12/17/2020
Onset Date: 12/17/2020
Rec V Date: 01/05/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Sat 12-19-20 red spot around injection site, Mon 12/21/20 it feels warm and itching the redness is larger PT states she has taken Benadryl for symptoms

Other Meds:

Current Illness:

ID: 0920998
Sex: M
Age:
State: HI

Vax Date: 12/23/2020
Onset Date: 12/23/2020
Rec V Date: 01/05/2021
Hospital:

Lab Data: Test Date: 20201223; Test Name: fevers; Result Unstructured Data: Test Result:99.5-101.5 Fahrenheit; Test Date: 20201227; Test Name: Nasal Swab; Result Unstructured Data: Test Result:Unknonwn results

Allergies:

Symptoms: Tiredness, chills, body aches, diarrhea, persistent fevers even with Tylenol or Motrin taken 99.5-101.5degF.; Tiredness, chills, body aches, diarrhea, persistent fevers even with Tylenol or Motrin taken 99.5-101.5degF.; Tiredness, chills, body aches, diarrhea, persistent fevers even with Tylenol or Motrin taken 99.5-101.5degF.; Tiredness, chills, body aches, diarrhea, persistent fevers even with Tylenol or Motrin taken 99.5-101.5degF.; Tiredness, chills, body aches, diarrhea, persistent fevers even with Tylenol or Motrin taken 99.5-101.5degF.; This is a spontaneous report from a contactable Nurse. A 43-years-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number: EL1284), intramuscularly on 23Dec2020 08:30 at single dose on Left arm for immunisation. The most recent COVID-19 vaccine was administered at Hospital. Medical history was none. No other vaccine in four weeks and two weeks. No covid prior vaccination. The patient's concomitant medications were not reported. The patient experienced tiredness, chills, body aches, diarrhea, persistent fevers even with tylenol or motrin taken 99.5-101.5degf on 23Dec2020 16:00. AE resulted in Doctor or other healthcare professional office/clinic visit. No treatment for tiredness, chills, body aches, diarrhea. The outcome was not recovered. Covid test post vaccination included Covid 19 with type of Nasal Swab on 27Dec2020 with unknown results.

Other Meds:

Current Illness:

ID: 0920999
Sex: F
Age:
State: MD

Vax Date: 12/26/2020
Onset Date: 12/26/2020
Rec V Date: 01/05/2021
Hospital:

Lab Data:

Allergies:

Symptoms: itching immediately after injection; then burning; then redness traveling up arm into chest; immediate onset of diarrhea; This is a spontaneous report from a contactable nurse(patient). A 42-year-old female non-pregnant patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number=el0140), intramuscular on 26Dec2020 09:30 at left arm at single dose for covid-19 immunization. The COVID-19 vaccine was administered at Hospital. The patient had no known allergies and no other medical history. The patient had no other vaccine in four weeks and no other medications in two weeks. The patient experienced itching immediately after injection, then burning, then redness traveling up arm into chest, and immediate onset of diarrhea. Adverse event start date was 26Dec2020 09:30 AM. The events result in emergency room/department or urgent care. Treatment of Pepcid, Benadryl and prednisone received. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient was not been tested for COVID-19. The outcome of the events was recovered in Dec2020.

Other Meds:

Current Illness:

ID: 0921000
Sex: F
Age:
State: CA

Vax Date: 12/17/2020
Onset Date: 12/27/2020
Rec V Date: 01/05/2021
Hospital:

Lab Data: Test Date: 20201227; Test Name: COVID test; Test Result: Positive

Allergies:

Symptoms: patient tested positive for COVID; patient tested positive for COVID; This is a spontaneous report from a contactable physician from a Pfizer-sponsored program Pfizer First Connect. A 29-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration on 17Dec2020 as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On 27Dec2020, the patient tested positive for COVID. The clinical outcome of patient tested positive for COVID was unknown. The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.; Sender's Comments: The efficacy of a drug varies from one patient to another and can be affected by different factors; however, a contributory role of the suspect drug BNT162B2 to the reported events Drug ineffective and COVID 19 cannot be ruled out.

Other Meds:

Current Illness:

ID: 0921001
Sex: M
Age: 58
State: NC

Vax Date: 12/22/2020
Onset Date: 12/31/2020
Rec V Date: 01/05/2021
Hospital:

Lab Data:

Allergies: NKDA

Symptoms: large bruising and redness, localized - delayed reaction

Other Meds:

Current Illness: none

ID: 0921002
Sex: F
Age:
State: IN

Vax Date: 12/18/2020
Onset Date: 12/19/2020
Rec V Date: 01/05/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Nerve pain in lower back shooting into buttocks, also on bilateral (bil) wrists.; Nerve pain in lower back shooting into buttocks, also on bilateral (bil) wrists.; This is a spontaneous report from a contactable nurse (patient). A 34-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot/batch number: EK5730), via an unspecified route of administration on the right arm on 18Dec2020 07:45 at SINGLE DOSE for COVID-19 immunization at the hospital. Medical history included Gyn issues, migraine and headaches but otherwise healthy. The patient also had allergies with sulfa, leminine, and latex sensitivity but not anaphylactic. Concomitant medications included elagolix sodium (ORILISSA), and calcium carbonate, colecalciferol, phytomenadione (VIACTIV). It was mentioned that prior to vaccination, the patient was not diagnosed with COVID-19 and had not been tested for COVID-19 since vaccination. On 19Dec2020 14:00, the patient experienced nerve pain in lower back shooting into buttocks, also on bilateral (bil) wrists. The patient did not receive any treatment for the events. Outcome of the events were not recovered.

Other Meds: ORILISSA; VIACTIV [CALCIUM CARBONATE;COLECALCIFEROL;PHYTOMENADIONE]

Current Illness:

ID: 0921003
Sex: F
Age:
State: SC

Vax Date:
Onset Date:
Rec V Date: 01/05/2021
Hospital:

Lab Data: Test Name: COVID-19; Result Unstructured Data: Test Result:got COVID-19

Allergies:

Symptoms: she was administered the first dose of Pfizer COVID-19 Vaccine and later got COVID-19; she was administered the first dose of Pfizer COVID-19 Vaccine and later got COVID-19; This is a spontaneous report from a Pfizer-sponsored program Pfizer First Connect. A contactable female physician (patient) of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date not reported), via an unspecified route of administration from an unspecified date in 2020 at a single dose for Covid-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date in 2020, the patient got the first shot of COVID vaccine and got COVID, she was wondering if she should still get the dose scheduled for 04Jan2021. The patient clarified that she is both a medical doctor/physician as well as the patient. She clarified that she was administered the first dose of Pfizer COVID-19 Vaccine and later got COVID-19. She called to ask if she should still get the second dose of COVID-19 Vaccine which is scheduled for 04Jan2021. She clarified that she does not think anything went wrong with the COVID-19 Vaccine. She does not think her receiving the COVID-19 Vaccine and developing COVID-19 are related; there was no way she would have had time to develop any protection from the COVID-19 Vaccine at the time she was exposed to COVID-19 2 days later. She does not think she can provide any relevant medical information that would be helpful for this report and declined to continue report. The outcome of the event was unknown. Information on the lot/batch number has been requested.; Sender's Comments: The reported "developing COVID-19" after COVID-19 immunization is considered ineffective of BNT162B2, and the Company cannot completely exclude the possible causality between the reported event and BNT162B2 administration.

Other Meds:

Current Illness:

ID: 0921004
Sex: F
Age: 69
State: TN

Vax Date: 12/28/2020
Onset Date: 12/28/2020
Rec V Date: 01/05/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Mild itching - no signs of distress at discontinuation of monitoring - asked to f/u w/ PCP

Other Meds:

Current Illness:

ID: 0921005
Sex: F
Age:
State: NY

Vax Date: 12/22/2020
Onset Date: 12/28/2020
Rec V Date: 01/05/2021
Hospital:

Lab Data: Test Date: 20201228; Test Name: COVID-19; Test Result: Positive

Allergies:

Symptoms: She tested positive for COVID-19; She tested positive for COVID-19; This is a spontaneous report from a contactable healthcare professional (patient) via Pfizer sales representative. A 55-years-old female patient received her first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date not reported), via an unspecified route of administration on 22Dec2020 at a single dose for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient, who is a frontline medical worker, informed that she tested positive for COVID-19 today (28Dec2020). The patient stated that she was informed by her employee health division at (place) that she was exposed to a patient with COVID-19 prior to her vaccination. She asked to be contacted regarding the timing of her second dose in light of her current status. The outcome of the event was unknown. Information on the lot/batch number has been requested.; Sender's Comments: There is not a reasonable possibility that reported "tested positive for COVID-19" is related to BNT162B2 vaccine. The patient exposed to a patient with COVID-19 before vaccination.

Other Meds:

Current Illness:

ID: 0921006
Sex: F
Age:
State:

Vax Date: 12/18/2020
Onset Date: 12/25/2020
Rec V Date: 01/05/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Not feeling well; chills; muscle aches; headache; ears bothering; stuffy/runny nose; stuffy/runny nose; This is a spontaneous report from a non-contactable nurse (patient). A 43-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number: EL0140), intramuscularly in the right arm, on 18Dec2020 at 06:00 (at the age of 43-years-old) at a single dose for COVID-19 immunization. Medical history included hypothyroid, breast cancer, and penicillin allergy. The patient was not pregnant at the time of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications, taken within two weeks of vaccination, included levothyroxine (MANUFACTURER UNKNOWN) and tamoxifen (MANUFACTURER UNKNOWN). Other concomitant medications included unspecified multivitamin. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient experienced not feeling well, chills, muscle aches, headache, ears bothering, and stuffy/runny nose on 25Dec2020 at 20:00. The events were reported as non-serious. No therapeutic measures were taken as a result of the events. The clinical outcome of not feeling well, chills, muscle aches, headache, ears bothering, and stuffy/runny nose was unknown. It was also reported that since the vaccination, the patient had not been tested for COVID-19. No follow-up attempts are possible. No further information is expected.

Other Meds: ;

Current Illness:

ID: 0921007
Sex: F
Age:
State: NJ

Vax Date: 12/28/2020
Onset Date: 12/28/2020
Rec V Date: 01/05/2021
Hospital:

Lab Data:

Allergies:

Symptoms: About 45 minutes after injection, got a bloody nose out of no where, then at night started having GI symptoms & low grade fever; About 45 minutes after injection, got a bloody nose out of no where, then at night started having GI symptoms & low grade fever; About 45 minutes after injection, got a bloody nose out of no where, then at night started having GI symptoms & low grade fever; This is a spontaneous report from a contactable other healthcare professional (patient). A 42-years-old female patient started to the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), intramuscularly on 28Dec2020 13:15 (at the age of 42-years-old) as a single dose in the left arm for COVID-19 immunization. Medical history included the patient had allergies to medications, food, or other products, Bactrim and Sulfa based medications, & food sensitivities. Concomitant medication included birth control. The patient previously took sulfamethoxazole and trimethoprim (BACTRIM) and experienced allergies to medications: BACTRIM. The most recent COVID-19 vaccine was administered in the hospital. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. On 28Dec2020 About 45 minutes after injection, patient got a bloody nose out of nowhere (14:00), then at night at 22:00 (10:00PM) started having gastrointestinal (GI) symptoms & low grade fever. The events bloody nose out of nowhere, then at night started having gastrointestinal (GI) symptoms & low grade fever did not result in death, was not life-threatening, did not cause/prolonged hospitalization, was not disabling/incapacitating and did not cause congenital anomaly/birth defect. No treatment was received for the events bloody nose out of nowhere, then at night started having gastrointestinal (GI) symptoms & low grade fever. Outcome of the events bloody nose out of nowhere, then at night started having gastrointestinal (GI) symptoms & low grade fever were recovering. Since the vaccination, the patient has not been tested for COVID-19. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0921008
Sex: F
Age:
State:

Vax Date: 12/22/2020
Onset Date: 12/25/2020
Rec V Date: 01/05/2021
Hospital:

Lab Data:

Allergies:

Symptoms: itchy rash on arms; This is a spontaneous report from a non-contactable other-HCP (patient). A 34-year-old non-pregnant female patient received 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EH9899), via an unspecified route of administration in the left arm on 22Dec2020 10:30 at a single dose for COVID-19 immunization at the hospital. The patient has no medical history. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced itchy rash on arms on 25Dec2020 12:00. Outcome of the event was recovering. The event resulted in doctor or other healthcare professional office/clinic visit. The patient received antihistamine for the event. The event was assessed as non-serious. The patient was not diagnosed with COVID-19 prior to vaccination and has not been tested for COVID-19 since the vaccination. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 0921009
Sex: F
Age: 65
State: MA

Vax Date: 01/04/2021
Onset Date: 01/04/2021
Rec V Date: 01/05/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Recipient reported pulsating around the injection site during the 15 minute observation period. HR- 77-82, O2- 100%

Other Meds:

Current Illness:

ID: 0921010
Sex: F
Age:
State: GA

Vax Date: 12/28/2020
Onset Date: 12/28/2020
Rec V Date: 01/05/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Very sore arm; This is a spontaneous report from a contactable nurse (patient). A 53-year-old non-pregnant female patient received 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EJ1685), intramuscular in the right arm on 28Dec2020 08:30 at a single dose for COVID-19 immunization at the hospital. Medical history included hypertension (HTN) and diabetes mellitus (DM). The patient has no known allergies. The patient had received unspecified other medications the patient received within 2 weeks of vaccination. The patient did not receive other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced very sore arm on 28Dec2020 12:00. Outcome of the event was not recovered. No treatment was given for the event. The patient was not diagnosed with COVID-19 prior to vaccination and has not been tested for COVID-19 post vaccination. The event was assessed as non-serious.

Other Meds:

Current Illness:

ID: 0921011
Sex: F
Age:
State: NJ

Vax Date: 12/24/2020
Onset Date: 12/24/2020
Rec V Date: 01/05/2021
Hospital:

Lab Data: Test Date: 20201224; Test Name: fever; Result Unstructured Data: Test Result:101.1 Fahrenheit; Test Date: 20201224; Test Name: fever; Result Unstructured Data: Test Result:100.6 Fahrenheit

Allergies:

Symptoms: fever. Highest temperature was 101.1 F. I took tylenol which only brought it down to 100.6 F an hour later. Fever lasted for 5 hours total; back aches/achiness were better after sleeping for the night; headache; Fatigue; This is a spontaneous report from a contactable nurse reporting for herself. A 31-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK9231), via an unspecified route of administration at left arm on 24Dec2020 08:30 at single dose for covid-19 immunization. It was the first dose. The COVID-19 vaccine was administered at Hospital. Medical history included Baseline leukopenia. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. About 12 hours after the vaccine the patient developed back aches, headache, and a fever. Highest temperature was 101.1 F. The patient took Tylenol which only brought it down to 100.6 F an hour later. Fever lasted for 5 hours total. Fatigue and achiness were better after sleeping for the night. Events onset date was provided as 24Dec2020 11:30 PM. No treatment was received for the events of back aches, headache and fatigue. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient has not been tested for COVID-19. The outcome of the event fever was recovered on 25Dec2020 04:30, the outcome of the other events back aches, headache and fatigue was recovered on an unknown date in Dec2020.

Other Meds:

Current Illness:

ID: 0921012
Sex: F
Age: 41
State: CA

Vax Date: 12/17/2020
Onset Date: 12/20/2020
Rec V Date: 01/05/2021
Hospital:

Lab Data: no

Allergies: no

Symptoms: 4 days the vaccine I got a high fever, body aches and tonsils were severly swollen and couldnt work

Other Meds: no

Current Illness: no

ID: 0921013
Sex: F
Age:
State: PA

Vax Date: 12/22/2020
Onset Date: 12/23/2020
Rec V Date: 01/05/2021
Hospital:

Lab Data:

Allergies:

Symptoms: episode of vertigo; vomiting; nausea; This is a spontaneous report from contactable physicians (one is the patient). A 41-year-old female patient received the first dose of bnt162b2 (BNT162B2, Solution for injection, lot number: EJ1685), via an unspecified route of administration on the left arm on 22Dec2020 at 12:45 at a single dose for immunization. Medical history included benign paroxysmal positional vertigo, but the patient has not had a flare of this condition in 3.5 years. The patient has no allergies to medications, food, or other products. Concomitant medications were not reported. The patient who has a history of Benign Paroxysmal Positional Vertigo (BPPV) had not had a flare of this condition in 3.5 years. Previously, it has only been brought on by scuba diving, then she woke up the day after receiving the Pfizer COVID 19 vaccine, on 23Dec2020 at 06:30 with an episode of vertigo consistent with prior episodes of BPPV. She has associated nausea and vomiting, and her symptoms mostly resolve with doing home exercises, rest and time. On 29Dec2020, that is day 7 after the vaccine and she still have mild vertigo. She has no fevers, chills, or myalgias. She stated that perhaps it was a coincidence but thought it might be worth reporting, and she fully intend to get the second Pfizer vaccine when available. No treatment was received for the events. Prior to vaccination, the patient was not diagnosed with COVID-19, and since the vaccination, the patient has not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine, and no other medications were received by the patient within 2 weeks of vaccination. The events nausea and vomiting resolved in 2020 while the rest of the events was resolving.

Other Meds:

Current Illness:

ID: 0921014
Sex: F
Age:
State: IN

Vax Date: 12/22/2020
Onset Date: 12/28/2020
Rec V Date: 01/05/2021
Hospital:

Lab Data:

Allergies:

Symptoms: itchy rash; This is a spontaneous report from a contactable nurse (patient). A 38-years-old female patient received the first dose of bnt162b2 (Pfizer BioNTech, Solution for injection, lot number: EK5730), via an unspecified route of administration on the left arm on 22Dec2020 17:45 at a single dose for immunization. Medical history was reported as none. The patient has no known allergies. The patient's concomitant medications were not reported. On 28Dec2020 at 06:00, 6 days after the initial Covid vaccine dose, the patient developed an itchy rash all over her body. Started first thing in the morning with itchy ankles, and by the afternoon, it was covering her whole body in patches and was intensely itchy. No other associated symptoms. No new detergent, clothing, foods, meds to explain. The patient left for work, showered, and took Benadryl. The rash went away and at the time of the report, feels fine. The patient was not diagnosed with COVID prior vaccination and was not tested post vaccination. The patient has no other vaccine in four weeks. The events resolved on an unspecified date in Dec2020.

Other Meds:

Current Illness:

ID: 0921015
Sex: F
Age: 57
State: TX

Vax Date: 01/02/2021
Onset Date: 01/04/2021
Rec V Date: 01/05/2021
Hospital:

Lab Data: N/A

Allergies: possibly shellfish, Lotrimin, macrodantin, Biaxin

Symptoms: Red, raised, warm pear-shaped area 3x5" noted 1/4/2021 @ 8:00 PM.I had used Benadryl 25mg night before for sneezing d/t putting Christmas stuff into attic. On Jan 4th, I used a cold compress and used Benadryl 50mg. I notified my Dr's office and pharmacy.

Other Meds: Lexapro, thyroid support supplement, Ca+, Mg+, D3, B12, Vit C, Stress supplement: lemon oil..., parsley, Vit E, Fish oil, glucosamine, L-lysine, Valtrex, Nexium, Diclofenac, Zyrtec, melatonin, Benadryl, meloxicam

Current Illness: possibly GI viral 11/30/2020. Chills, diarrhea x1, slight H/A, muscle aches. Tested negative for COVID 19. I would like to also make you aware that with the first Shingles vaccination, I had 2 herpetic lesions breakout that I had not had break out in decades. I had to double to Valtrex for 3 weeks.

ID: 0921016
Sex: F
Age:
State: MI

Vax Date: 12/28/2020
Onset Date: 12/28/2020
Rec V Date: 01/05/2021
Hospital:

Lab Data:

Allergies:

Symptoms: had a little side step/unbalance moment; left hand started tingling/tingling in left foot and left side of face; neck on left side felt like someone had hit it; injection site and whole deltoid was numb.; Left side of face, left foot and left ear all felt numb but with tingles; This is a spontaneous report from a contactable other HCP (patient). A 48-year-old female patient (not pregnant) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number=EL0140), via an unspecified route of administration in Left arm on 28Dec2020 16:30 at single dose for covid-19 immunisation. The COVID-19 vaccine was administered at workplace clinic. Medical history included known allergies to food - vegetables, berries, shellfish, environmental. Concomitant medication in two weeks included desogestrel, ethinylestradiol (MIRCETTE), fluticasone propionate (FLONASE), iron, multi vitamin, elderberry w/z. The patient previously took benzoyl peroxide and experienced drug hypersensitivity. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient waited 20min, went up to leave and while walking out had a little side step/unbalance moment. The patient thought nothing of it and went to car and was waiting in car for an extra 10 min. Her left hand started tingling, same tingling like if it was asleep and was waking up. Then she started to drive home, on the way home, noticed tingling in left foot and left side of face, neck on left side felt like someone had hit it. About 50 min after receiving injection, was at home, injection site and whole deltoid was numb. Left side of face, left foot and left ear all felt numb but with tingles. She had stopped timer after 2 hours. Tingling and numbness subsided sometime after 2 hours of receiving vaccine. Today (29Dec2020), everything felt fine. Injection site just felt like I got a shot, can barely notice it. Adverse event start date provided as 28Dec2020 05:15 PM. No treatment received for the events. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient was not been tested for COVID-19. The outcome of the events was recovered on 29Dec2020.

Other Meds: MIRCETTE; FLONASE [FLUTICASONE PROPIONATE];

Current Illness:

ID: 0921017
Sex: F
Age:
State: FL

Vax Date: 12/22/2020
Onset Date: 12/22/2020
Rec V Date: 01/05/2021
Hospital:

Lab Data: Test Date: 20201222; Test Name: temperature; Result Unstructured Data: Test Result:high

Allergies:

Symptoms: fatigue; Swollen left elbow (tender to touch); dizziness; headaches; high temperature; Swollen left elbow (tender to touch); This is a spontaneous report from a contactable other health professional (HCP, reported for herself). A 44-year-old female patient (not pregnant at the time of vaccination) received the first dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: 1830), intramuscular on 22Dec2020 12:45 at single dose at left arm for COVID-19 immunization. Medical history and concomitant medications were none. Facility where the most recent COVID-19 vaccine was administered at Hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other medications within 2 weeks of vaccination. On 22Dec2020 16:45 (04:45 PM), the patient experienced swollen left elbow (tender to touch), dizziness/headaches, high temperature, fatigue. The adverse events resulted in doctor or other healthcare professional office/clinic visit. No treatment received for the adverse events. The events were non-serious per the reporter. Prior to vaccination, the patient wasn't diagnosed with COVID-19. Since the vaccination, the patient hadn't been tested for COVID-19. The outcome of the events was recovering.

Other Meds:

Current Illness:

ID: 0921018
Sex: M
Age:
State: IL

Vax Date: 12/28/2020
Onset Date: 12/28/2020
Rec V Date: 01/05/2021
Hospital:

Lab Data: Test Date: 20201228; Test Name: BP; Result Unstructured Data: Test Result:160/85

Allergies:

Symptoms: eye irritation; eyes turn red; blurry vision; difficulty keeping eyes open; BP 160/85; This is a spontaneous report from a contactable other hcp (patient). A 50-year-old male patient received bnt162b2 (lot number: EL0140), intramuscularly at arm left, first dose on 28Dec2020, at single dose, for COVID-19 immunization. The patient medical history was not reported. There were no concomitant medications. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. No allergies to medications, food, or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other medications the within 2 weeks of vaccination. The patient experienced eye irritation, eyes turn red, blurry vision, difficulty keeping eyes open, BP 160/85 on 28Dec2020. No treatment received for the adverse event. The event was reported as non-serious. The outcome of the events was recovering.

Other Meds:

Current Illness:

ID: 0921019
Sex: F
Age: 38
State: DE

Vax Date: 12/28/2020
Onset Date: 12/28/2020
Rec V Date: 01/05/2021
Hospital:

Lab Data: None. Required diphenhydramine PO 50mg first dose then 25mg every 6 hours for about 36 hours to reduce itching to tolerable level

Allergies: Iodine contrast (anaphylaxis) Latex (rash) Steri-strips (rash, hives)

Symptoms: Urticaria, diffuse flushing head to toe, significant pruritus, tachycardia

Other Meds: Venlafaxine, emgality, ibuprofen, d3, b12, folic acid

Current Illness: None

ID: 0921020
Sex: F
Age:
State: KS

Vax Date: 12/17/2020
Onset Date: 12/25/2020
Rec V Date: 01/05/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Vertigo/it is now full blown vertigo; Stuffy head; She does not feel safe walking in her home; Nausea/ Acute nausea; Dizziness; This is a spontaneous report from a contactable consumer (patient). A 55-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EK3730, expiration date: 20Mar2021), via an unspecified route of administration on 17Dec2020 at left deltoid, at single dose for covid-19 immunization. Medical history included patent foramen ovale in patient's heart from 2013 and ongoing, and the patient used to be 5'4" and noticed the shrinkage before the Covid 19 vaccine and baby aspirin. Concomitant medication included acetylsalicylic acid (BABY ASPIRIN) from 2013 and ongoing for patent foramen ovale. The patient got the Pfizer vaccine on 17Dec2020 and on 25Dec2020 had experienced acute nausea and dizziness that persisted during weekend. Stated that it is now full blown vertigo. Stated that her doctor and pharmacist stated that people reported symptoms but did not know if these were symptoms of the vaccine because it is not listed. The patient experienced stuff head on 28Dec2020. Stated that the nausea comes and goes. Stated that she got physical therapy treatment Epley for vertigo on 28Dec2020 and it did some good but she woke it with it again this morning on 29Dec2020. Stated that the therapy lessened her nausea as well. Stated vertigo was manageable 25-26 and then did not feel safe walking in her home on 26Dec2020. Stated that she had no symptoms after she received it up until 25Dec2020. Stated that she will get the second dose 07Jan2021. The outcome of the events was not recovered.

Other Meds: BABY ASPIRIN

Current Illness: Foramen ovale patent

ID: 0921021
Sex: F
Age: 44
State: CA

Vax Date: 12/30/2020
Onset Date: 12/31/2020
Rec V Date: 01/05/2021
Hospital:

Lab Data:

Allergies:

Symptoms: FEVER, CHILLS, BODY ACHES, MALAISE

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 134,999

Page last modified: 14 December 2021 10:42pm